Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04317118 · ClinicalTrials.gov registry record

Ask Suicide-Screening Questions (ASQ) for Youth With Autism Spectrum and Neurodevelopmental Disorders

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
278
Enrollment target

NCT04317118 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 278 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04317118 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
278 participants
Enrollment target

Study Summary

Background: Suicide is the second leading cause of death for young people ages 10-24 years. There is no gold standard for evaluating suicidal thoughts and behaviors in young people with autism spectrum disorder (ASD) or other neurodevelopmental disorders (NDD). Also, youth with ASD/NDD are often excluded from many research studies. Because of this, researchers need more data. They want to make sure they are asking the best questions for young people in clinics such as the National Institute of Mental Health (NIMH) clinic. They want to make sure they have the best data to determine if a person is at risk for hurting or killing himself or herself. Objective: To develop and assess the efficacy of a suicide screening tool for people with ASD/NDD. Eligibility: Youth ages 8 to 17 who are engaged in assessment or treatment at the NIMH for ASD or other NDD Design: Participants will fill out 4 questionnaires during a 1-hour meeting with study staff. They will answer questions about how they have been feeling. They will be asked if they think about or plan to hurt or kill themselves. They will also be asked if they have ever thought about it or planned it in the past. Other questions will assess their understanding of death. Participants can take a break if needed. Parents of the participants will be asked similar questions. Parents will be informed if their child has current thoughts of suicide. About 1 week after the initial assessment, parents will be contacted to fill out a follow-up questionnaire. It will take about 10 minutes to complete.

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2021-07-15
Est. Completion 2025-09-09

What the Registry Record Tells You About NCT04317118

The ClinicalTrials.gov registry entry for NCT04317118 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04317118 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04317118 about?

NCT04317118 is a clinical study titled "Ask Suicide-Screening Questions (ASQ) for Youth With Autism Spectrum and Neurodevelopmental Disorders". Background: Suicide is the second leading cause of death for young people ages 10-24 years. There is no gold standard for evaluating suicidal thoughts and behaviors in young people with autism spectrum disorder (ASD) or other neurodevelopmental disorders (NDD). Also, youth with ASD/NDD are often ex...

What is the current status of trial NCT04317118?

This trial is currently completed. The enrollment target is 278 participants. The study started on 2021-07-15. Estimated completion is 2025-09-09.

Who is sponsoring clinical trial NCT04317118?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.